S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Celldex Therapeutics (CLDX) Insider Trading & Ownership

$37.98
-0.55 (-1.43%)
(As of 04/19/2024 ET)

Celldex Therapeutics (NASDAQ:CLDX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.70%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$19,900.40
Number Of
Insiders Selling
(Last 3 Years)
4
Amount Of
Insider Selling
(Last 3 Years)
$3.38 M
Get CLDX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Celldex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CLDX Insider Buying and Selling by Quarter

Celldex Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2022Sarah CavanaughSVPSell31,312$36.73$1,150,089.76  
8/12/2022Samuel Bates MartinCFOSell17,547$36.45$639,588.15  
12/23/2021Samuel Bates MartinCFOSell9,500$42.00$399,000.00  
12/8/2021Elizabeth CrowleyVPSell4,000$40.00$160,000.00  
12/8/2021Sarah CavanaughSVPSell7,323$40.00$292,920.00  
11/15/2021Samuel Bates MartinCFOSell9,500$43.57$413,915.00  
11/12/2021Diane C YoungSVPSell4,600$42.94$197,524.00  
8/11/2021Freddy A JimenezSVPBuy430$46.28$19,900.40  
8/10/2021Samuel Bates MartinCFOSell2,738$45.25$123,894.50  
(Data available from 1/1/2013 forward)

CLDX Insider Trading Activity - Frequently Asked Questions

Who is on Celldex Therapeutics's Insider Roster?
What percentage of Celldex Therapeutics stock is owned by insiders?

3.70% of Celldex Therapeutics stock is owned by insiders. Learn more on CLDX's insider holdings.

Which Celldex Therapeutics insiders have been selling company stock?

The following insiders have sold CLDX shares in the last 24 months: Samuel Bates Martin ($639,588.15), and Sarah Cavanaugh ($1,150,089.76).

How much insider selling is happening at Celldex Therapeutics?

Insiders have sold a total of 48,859 Celldex Therapeutics shares in the last 24 months for a total of $1,789,677.91 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:CLDX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners